189 related articles for article (PubMed ID: 8585400)
41. The dose of levothyroxine in pregnant women with hypothyroidism should be increased by 20-30% in the first trimester.
Hubaveshka J; Michaelsson LF; Nygaard B
Dan Med J; 2014 Dec; 61(12):A4959. PubMed ID: 25441726
[TBL] [Abstract][Full Text] [Related]
42. Increased need for thyroxine in women with hypothyroidism during estrogen therapy.
Arafah BM
N Engl J Med; 2001 Jun; 344(23):1743-9. PubMed ID: 11396440
[TBL] [Abstract][Full Text] [Related]
43. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
[TBL] [Abstract][Full Text] [Related]
44. Timing of levothyroxine administration affects serum thyrotropin concentration.
Bach-Huynh TG; Nayak B; Loh J; Soldin S; Jonklaas J
J Clin Endocrinol Metab; 2009 Oct; 94(10):3905-12. PubMed ID: 19584184
[TBL] [Abstract][Full Text] [Related]
45. The serum concentrations of T3, T4 and TSH in evaluating replacement therapy in primary hypothyroidism.
Bindels AJ; Meinders AE
Neth J Med; 1988 Feb; 32(1-2):59-71. PubMed ID: 3347327
[No Abstract] [Full Text] [Related]
46. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study.
Del Duca SC; Santaguida MG; Brusca N; Gatto I; Cellini M; Gargano L; Verga Falzacappa C; Frattaroli FM; Virili C; Centanni M
Eur J Endocrinol; 2015 Sep; 173(3):351-7. PubMed ID: 26092761
[TBL] [Abstract][Full Text] [Related]
47. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
48. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
Green WL
AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones.
Snyder PJ; Utiger RD
J Clin Invest; 1972 Aug; 51(8):2077-84. PubMed ID: 4626582
[TBL] [Abstract][Full Text] [Related]
50. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
51. Basal Serum Thyroxine Level should Guide Initial Thyroxine Replacement Dose in Neonates with Congenital Hypothyroidism.
Günbey C; Özön A; Gönç EN; Alikaşifoğlu A; Karahan S; Kandemir N
J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):269-275. PubMed ID: 33374096
[TBL] [Abstract][Full Text] [Related]
52. Circadian and Circannual Rhythms in Thyroid Hormones: Determining the TSH and Free T4 Reference Intervals Based Upon Time of Day, Age, and Sex.
Ehrenkranz J; Bach PR; Snow GL; Schneider A; Lee JL; Ilstrup S; Bennett ST; Benvenga S
Thyroid; 2015 Aug; 25(8):954-61. PubMed ID: 26061389
[TBL] [Abstract][Full Text] [Related]
53. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
54. Solitary nodular disease and multinodular goiter: a retrospective study on suppressive versus replacement levothyroxine therapy.
Paggi A; Persegani-Trimarchi C; Russo P; Mastropasqua M; Mosetti MA; Losi T; Leri O
Endocr Res; 1999 May; 25(2):229-38. PubMed ID: 10382684
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.
Ferretti E; Persani L; Jaffrain-Rea ML; Giambona S; Tamburrano G; Beck-Peccoz P
J Clin Endocrinol Metab; 1999 Mar; 84(3):924-9. PubMed ID: 10084572
[TBL] [Abstract][Full Text] [Related]
56. Transient TRH deficiency after prolonged thyroid hormone therapy.
Singer PA; Nicoloff JT; Stein RB; Jaramillo J
J Clin Endocrinol Metab; 1978 Sep; 47(3):512-8. PubMed ID: 122410
[TBL] [Abstract][Full Text] [Related]
57. Dysthyronemia in normal concentrations of thyrotropin--analytical and clinical consequences.
Bílek R; Stárka L; Zamrazil V
Horm Mol Biol Clin Investig; 2013 Jun; 13(2):13-7. PubMed ID: 25436710
[TBL] [Abstract][Full Text] [Related]
58. Levothyroxine Therapy in Elderly Patients With Hypothyroidism.
Effraimidis G; Watt T; Feldt-Rasmussen U
Front Endocrinol (Lausanne); 2021; 12():641560. PubMed ID: 33790867
[TBL] [Abstract][Full Text] [Related]
59. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.
Taylor PN; Iqbal A; Minassian C; Sayers A; Draman MS; Greenwood R; Hamilton W; Okosieme O; Panicker V; Thomas SL; Dayan C
JAMA Intern Med; 2014 Jan; 174(1):32-9. PubMed ID: 24100714
[TBL] [Abstract][Full Text] [Related]
60. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
